Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Claes Öhlén is active.

Publication


Featured researches published by Claes Öhlén.


Immunology Today | 1992

Allorecognition by NK cells: nonself or no self?

Lorenzo Moretta; Ermanno Ciccone; Alessandro Moretta; Petter Höglund; Claes Öhlén; Klas Kärre

The issue of antigen recognition by NK cells is complex, fascinating and, as yet, unresolved. This article reviews recent research on the repertoire of human NK cell clones for the recognition of different allogeneic cells, and summarizes the studies, most of which have been performed in mice, that implicate the MHC in NK cell recognition. It goes on to provide a common conceptual framework within which these different systems may be understood.


Cold Spring Harbor Symposia on Quantitative Biology | 1989

A mutant cell in which association of class I heavy and light chains is induced by viral peptides.

Alain Townsend; Claes Öhlén; L. Foster; Judy Bastin; Hans-Gustaf Ljunggren; Klas Kärre

Association of the Db heavy chain with beta 2-microglobulin and expression of Db and Kb at the surface of the cell are induced by specific peptides in the mutant RMA-S. Association of antigenic peptides with the binding site of class I molecules may be required for correct folding of the heavy chain, association with beta 2-microglobulin, and transport of the antigen-MHC complex to the cell surface.


Cellular Immunology | 1989

Enhanced H-2 expression and T-cell-dependent rejection after intracerebral transplantation of the murine lymphoma YAC-1

Toshiki Yamasaki; Hans-Gustaf Ljunggren; Claes Öhlén; George Klein; Klas Kärre

The relationship between MHC class I (H-2) expression and tumorigenicity was investigated after intracerebral inoculation of the murine lymphoma YAC-1 and its H-2 negative variant, A.H-2-. YAC-1 was less tumorigenic than A.H-2- in normal as well as NK-depleted syngeneic A/Sn mice. However, in T-cell-depleted syngeneic mice YAC-1 was as tumorigenic as A.H-2-. Following intracerebral growth, the H-2 expression of YAC-1 was markedly enhanced in a similar fashion as after intraperitoneal passage. The A.H-2- variant remained H-2 negative after intracranial passage. The H-2 negative variant cells were not rejected from the brain even when intermixed with wild-type YAC-1 cells prior to intracerebral inoculation, excluding an innocent bystander effect. In vitro, the intracerebrally passaged YAC-1 line showed enhanced sensitivity to lysis by H-2 Kk Dd (H-2a) specific CTLs but decreased sensitivity to NK cells. The A.H-2- line was unchanged. Our data suggest that the lack of H-2 molecules may facilitate the growth of antigenic tumor cells in the brain due to escape from T-cell-mediated immunosurveillance. Our data also suggest, in line with other recent findings, that intracerebrally growing tumor cells are sheltered from NK cell-mediated rejection.


Nature | 1989

Association of class I major histocompatibility heavy and light chains induced by viral peptides

Alain Townsend; Claes Öhlén; Judy Bastin; Hans-Gustaf Ljunggren; L. Foster; Klas Kärre


Nature | 1990

Empty MHC class I molecules come out in the cold

Hans-Gustaf Ljunggren; Nico J. Stam; Claes Öhlén; Jacques Neefjes; Petter Höglund; Marie-Therese Heemels; Judy Bastin; Ton N. M. Schumacher; Alain Townsend; Klas Kärre; Hidde L. Ploegh


Proceedings of the National Academy of Sciences of the United States of America | 1991

Recognition of beta 2-microglobulin-negative (beta 2m-) T-cell blasts by natural killer cells from normal but not from beta 2m- mice: nonresponsiveness controlled by beta 2m- bone marrow in chimeric mice.

Petter Höglund; Claes Öhlén; Ennio Carbone; Lars Franksson; Hans-Gustaf Ljunggren; A Latour; Beverly H. Koller; Klas Kärre


European Journal of Immunology | 1991

Different types of allospecific CTL clones identified by their ability to recognize peptide loading-defective target cells

Fumie Aosai; Claes Öhlén; Hans-Gustaf Ljunggren; Petter Höglund; Lars Franksson; Hidde Ploegh; Alain Townsend; Kias Kärre; Hans J. Stauss


Proceedings of the National Academy of Sciences of the United States of America | 1992

Major histocompatibility complex class I-specific and -restricted killing of beta 2-microglobulin-deficient cells by CD8+ cytotoxic T lymphocytes

Rickard Glas; Lars Franksson; Claes Öhlén; Petter Höglund; Beverly H. Koller; Hans-Gustaf Ljunggren; Klas Kärre


International Journal of Cancer | 1989

NK sensitivity and lung clearance of MHC-class-I-deficient cells within a heterogeneous fibrosarcoma

Ignacio Algarra; Claes Öhlén; Matias Perez; Hans-Gustaf Ljunggren; George Klein; Federico Garrido; Klas Kärre


European Journal of Immunology | 1995

Inhibition of natural killer cell‐mediated bone marrow graft rejection by allogeneic major histocompatibility complex class I, but not class II molecules

Claes Öhlén; Petter Höglund; Charles L. Sentman; Ennio Carbone; Hans-Gustaf Ljunggren; Beverly H. Koller; Klas Kärre

Collaboration


Dive into the Claes Öhlén's collaboration.

Top Co-Authors

Avatar

Hans-Gustaf Ljunggren

Karolinska University Hospital

View shared research outputs
Top Co-Authors

Avatar

Klas Kärre

University of Regensburg

View shared research outputs
Top Co-Authors

Avatar

Petter Höglund

Karolinska University Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Judy Bastin

John Radcliffe Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

George Klein

University of Regensburg

View shared research outputs
Top Co-Authors

Avatar

L. Foster

John Radcliffe Hospital

View shared research outputs
Top Co-Authors

Avatar

Beverly H. Koller

University of North Carolina at Chapel Hill

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge